OptimizeRx OPRX Earnings Call Transcripts

NASDAQ OPRX
$8.76 +0.09 (+1.04%)
At close: Nov 6, 2026 · 4:00 PM EST
8 earnings calls on file for OptimizeRx, from Q4 2020 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

OptimizeRx Q2 2026 Earnings Call

Aug 12, 2026 6,598 words · 29 min read
  • Stephen L. SilvestroChief Executive Officer
  • Edward StelmakhChief Financial Strategy Officer
  • Marion Odence-FordChief Legal and Administrative Officer
  • Andrew D'SilvaChief Business Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

OptimizeRx Earnings Call Transcripts

Calls8
LatestAug 12, 2026
SinceQ4 2020

Fiscal 2026

Fiscal 2025

Fiscal 2022

Fiscal 2021

Fiscal 2020

All 8 OptimizeRx transcripts Register to get access to OptimizeRx’s earnings call transcripts.